Elisabetta Rovida Selected Research

Mitogen-Activated Protein Kinase 7

10/2021	The Hedgehog-GLI Pathway Regulates MEK5-ERK5 Expression and Activation in Melanoma Cells.
10/2021	Extracellular Signal-Regulated Kinase 5 Regulates the Malignant Phenotype of Cholangiocarcinoma Cells.
1/2020	Beyond Kinase Activity: ERK5 Nucleo-Cytoplasmic Shuttling as a Novel Target for Anticancer Therapy.
10/2018	Targeting the Extracellular Signal-Regulated Kinase 5 Pathway to Suppress Human Chronic Myeloid Leukemia Stem Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elisabetta Rovida Research Topics

Disease

20	Neoplasms (Cancer) 05/2022 - 01/2011
11	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 05/2022 - 02/2011
7	Leukemia 10/2018 - 05/2007
7	Hypoxia (Hypoxemia) 01/2017 - 05/2007
6	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2013
5	Residual Neoplasm 08/2021 - 01/2014
4	Melanoma (Melanoma, Malignant) 01/2022 - 01/2014
4	Cholangiocarcinoma 10/2021 - 01/2019
3	Inflammation (Inflammations) 06/2015 - 03/2008
2	Liver Neoplasms (Liver Cancer) 01/2022 - 02/2015
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2013 - 12/2003
1	Fibrosis (Cirrhosis) 04/2022
1	Alcoholic Fatty Liver 04/2022
1	Cicatrix (Scar) 04/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Oncogene Addiction 01/2017
1	Ascites 01/2016
1	Chronic Disease (Chronic Diseases) 01/2014
1	Ischemia 01/2014
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2014
1	Genomic Instability 01/2013
1	Breast Neoplasms (Breast Cancer) 01/2011
1	Acute Erythroblastic Leukemia (Erythroleukemia) 05/2007

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2011
6	Mitogen-Activated Protein KinasesIBA 05/2022 - 09/2015
6	Oxygen (Dioxygen)IBA 08/2021 - 05/2007
5	Tyrosine Kinase InhibitorsIBA 08/2021 - 01/2014
5	Imatinib Mesylate (Gleevec)FDA Link 10/2020 - 02/2011
4	Mitogen-Activated Protein Kinase 7IBA 10/2021 - 10/2018
3	Pharmaceutical PreparationsIBA 10/2019 - 12/2003
3	Biological ProductsIBA 03/2019 - 09/2015
3	Glucose (Dextrose)FDA LinkGeneric 01/2014 - 02/2011
2	XMD 8-92IBA 01/2022 - 09/2015
2	Messenger RNA (mRNA)IBA 10/2021 - 02/2011
2	Glutamine (L-Glutamine)FDA Link 08/2021 - 01/2014
2	Histones (Histone)IBA 02/2013 - 12/2003
2	Macrophage Colony-Stimulating FactorIBA 01/2011 - 03/2008
1	Lactic Acid (Lactate)FDA LinkGeneric 05/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 04/2022
1	c-Mer Tyrosine KinaseIBA 04/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	JNK Mitogen-Activated Protein KinasesIBA 01/2022
1	GalactosidasesIBA 01/2022
1	Mitogen-Activated Protein Kinase 3IBA 01/2022
1	Cyclin-Dependent Kinase Inhibitor p21IBA 01/2022
1	Small Interfering RNA (siRNA)IBA 10/2021
1	GoldIBA 02/2021
1	ponatinibIBA 10/2020
1	Casein Kinase II (Casein Kinase 2)IBA 10/2019
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 10/2019
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 10/2019
1	derazantinibIBA 10/2019
1	ChemokinesIBA 01/2019
1	CXCR4 Receptors (CXCR4 Receptor)IBA 01/2019
1	VemurafenibIBA 01/2018
1	Oxidoreductases (Dehydrogenase)IBA 02/2017
1	Methotrexate (Mexate)FDA LinkGeneric 02/2017
1	5,6,7,8-tetrahydrofolic acid (tetrahydrofolate)IBA 02/2017
1	dihydrofolateIBA 02/2017
1	bcr-abl Fusion ProteinsIBA 01/2017
1	AcriflavineIBA 01/2017
1	Epidermal Growth Factor (EGF)IBA 09/2015
1	Dinoprostone (PGE2)FDA Link 06/2015
1	GTP-Binding Proteins (G-Protein)IBA 06/2015
1	ProstaglandinsIBA 06/2015
1	LipidsIBA 04/2015
1	Cysteine Proteases (Cysteine Protease)IBA 02/2015
1	ChromatinIBA 02/2015
1	Pyruvic Acid (Pyruvate)IBA 01/2014
1	Histone Deacetylase InhibitorsIBA 02/2013
1	Vorinostat FDA Link 02/2013
1	CarcinogensIBA 01/2013
1	Transcription Factors (Transcription Factor)IBA 01/2013
1	o-AminoazotolueneIBA 01/2013
1	Bortezomib (Velcade)FDA Link 02/2011
1	Cyclin D1IBA 01/2011
1	Core Binding Factors (Core-Binding Factor)IBA 12/2003
1	Butyrates (Butyrate)IBA 12/2003

Therapy/Procedure

10	Therapeutics 08/2021 - 01/2011
2	Immunotherapy 01/2018 - 04/2015
1	Drug Therapy (Chemotherapy) 10/2021
1	Subcutaneous Injections 10/2021
1	Precision Medicine 02/2021